| 1 |
Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3): 211-224.
|
| 2 |
Robbins TW, Vaghi MM, Banca P. Obsessive-compulsive disorder: puzzles and prospects[J]. Neuron, 2019, 102(1): 27-47.
|
| 3 |
Cryan JF, O′Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99(4): 1877-2013.
|
| 4 |
Kundu P, Blacher E, Elinav E, et al. Our gut microbiome: the evolving inner self[J]. Cell, 2017, 171(7): 1481-1493.
|
| 5 |
Turna J, Grosman Kaplan K, Patterson B, et al. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder[J]. J Psychiatr Res, 2019, 118: 1-6.
|
| 6 |
Liu YX, Zhang L, Wang XQ, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression[J]. Clin Gastroenterol Hepatol, 2016, 14(11): 1602-1611.e5.
|
| 7 |
Barzilay R, Patrick A, Calkins ME, et al. Association between early-life trauma and obsessive compulsive symptoms in community youth[J]. Depress Anxiety, 2019, 36(7): 586-595.
|
| 8 |
Michels N, van de Wiele T, Fouhy F, et al. Gut microbiome patterns depending on children′s psychosocial stress: reports versus biomarkers[J]. Brain Behav Immun, 2019, 80: 751-762.
|
| 9 |
Siopi E, Chevalier G, Katsimpardi L, et al. Changes in gut microbiota by chronic stress impair the efficacy of fluoxetine[J]. Cell Rep, 2020, 30(11): 3682-3690.e6.
|
| 10 |
Sinopoli VM, Burton CL, Kronenberg S, et al. A review of the role of serotonin system genes in obsessive-compulsive disorder[J]. Neurosci Biobehav Rev, 2017, 80: 372-381.
|
| 11 |
Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases[J]. Am J Psychiatry, 1998, 155(2): 264-271.
|
| 12 |
Quagliariello A, Del Chierico F, Russo A, et al. Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections[J]. Front Microbiol, 2018, 9: 675.
|
| 13 |
Turna J, Grosman Kaplan K, Anglin R, et al. The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study[J]. Acta Psychiatr Scand, 2020, 142(4): 337-347.
|
| 14 |
Domènech L, Willis J, Alemany M, et al. Changes in the stool and oropharyngeal microbiome in obsessive-compulsive disorder[EB/OL]. medRxiv, 2020. DOI: 10.1101/2020.05.26.20113779.
|
| 15 |
Traina G. Mast cells in gut and brain and their potential role as an emerging therapeutic target for neural diseases[J]. Front Cell Neurosci, 2019, 13: 345.
|
| 16 |
Zhu SB, Jiang YF, Xu KL, et al. The progress of gut microbiome research related to brain disorders[J]. J Neuroinflammation, 2020, 17(1): 1-20.
|
| 17 |
Rivière A, Selak M, Lantin D, et al. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut[J]. Front Microbiol, 2016, 7: 979.
|
| 18 |
Frodl T, O′Keane V. How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans[J]. Neurobiol Dis, 2013, 52: 24-37.
|
| 19 |
Şimşek Ş, Gençoğlan S, Yüksel T, et al. Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder[J]. J Clin Psychiatry, 2016, 77(7): e855-e859.
|
| 20 |
de Punder K, Pruimboom L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability[J]. Front Immunol, 2015, 6: 223.
|
| 21 |
Kelly JR, Kennedy PJ, Cryan JF, et al. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders[J]. Front Cell Neurosci, 2015, 9: 392.
|
| 22 |
Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood[J]. JAMA, 2000, 284(5): 592-597.
|
| 23 |
Ait-Belgnaoui A, Colom A, Braniste V, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice[J]. Neurogastroenterol Motil, 2014, 26(4): 510-520.
|
| 24 |
Grados M, Prazak M, Saif A, et al. A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models[J]. Expert Opin Drug Discov, 2016, 11(1): 27-43.
|
| 25 |
Stuchlik A, Radostová D, Hatalova H, et al. Validity of quinpirole sensitization rat model of OCD: linking evidence from animal and clinical studies[J]. Front Behav Neurosci, 2016, 10: 209.
|
| 26 |
Jung TD, Jung PS, Raveendran L, et al. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole[J]. Behav Pharmacol, 2018, 29(2 and 3-Spec Issue): 211-224.
|
| 27 |
Desbonnet L, Garrett L, Clarke G, et al. The probiotic bifidobacteria infantis: an assessment of potential antidepressant properties in the rat[J]. J Psychiatr Res, 2008, 43(2): 164-174.
|
| 28 |
Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment[J]. JAMA, 2017, 317(13): 1358-1367.
|
| 29 |
Fülling C, Dinan TG, Cryan JF. Gut microbe to brain signaling: what happens in vagus…[J]. Neuron, 2019, 101(6): 998-1002.
|
| 30 |
Suarez AN, Hsu TM, Liu CM, et al. Gut vagal sensory signaling regulates hippocampus function through multi-order pathways[J]. Nat Commun, 2018, 9(1): 2181.
|
| 31 |
Lyte M, Li W, Opitz N, et al. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium[J]. Physiol Behav, 2006, 89(3): 350-357.
|
| 32 |
Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve[J]. PNAS, 2011, 108(38): 16050-16055.
|
| 33 |
Sgritta M, Dooling SW, Buffington SA, et al. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder[J]. Neuron, 2019, 101(2): 246-259. e6.
|
| 34 |
Jackson MA, Verdi S, Maxan ME, et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort[J]. Nat Commun, 2018, 9(1): 2655.
|
| 35 |
Sun LJ, Zhang HH, Cao Y, et al. Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice[J]. Int J Med Sci, 2019, 16(9): 1260-1270.
|
| 36 |
Fung TC, Vuong HE, Luna CDG, et al. Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut[J]. Nat Microbiol, 2019, 4(12): 2064-2073.
|
| 37 |
Lyte M, Daniels KM, Schmitz-Esser S. Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects[J]. PeerJ, 2019, 7: e6199.
|
| 38 |
Farhood Z, Ong AA, Discolo CM. PANDAS: a systematic review of treatment options[J]. Int J Pediatr Otorhinolaryngol, 2016, 89: 149-153.
|
| 39 |
Esalatmanesh S, Abrishami Z, Zeinoddini A, et al. Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: a placebo-controlled, double-blind, randomized trial[J]. Psychiatry Clin Neurosci, 2016, 70(11): 517-526.
|
| 40 |
Rodriguez CI, Bender J Jr, Marcus SM, et al. Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial[J]. J Clin Psychiatry, 2010, 71(9): 1247-1249.
|
| 41 |
Kantak PA, Bobrow DN, Nyby JG. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG)[J]. Behav Pharmacol, 2014, 25(1): 71-79.
|
| 42 |
Messaoudi M, Violle N, Bisson JF, et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers[J]. Gut Microbes, 2011, 2(4): 256-261.
|
), 王振(